Electra Therapeutics, Inc. — Form D

Electra Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-30. The offering totals $184.1M, of which $134.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-10-30
• Form: D
• Accession: 0001231919-25-000372
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $184.1M
• Amount sold: $134.2M
• Remaining: $49.9M
• Investors: 19
• Date of first sale: 2025-10-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-562489

Issuer

• Name: Electra Therapeutics, Inc.
• CIK: 0002088082
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
• Phone: (888) 743-2290

Officers, directors & promoters (7)

More

• CIK 2088082 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search